142 related articles for article (PubMed ID: 15380190)
21. Structural and thermodynamic analyses of α-L-fucosidase inhibitors.
Lammerts van Bueren A; Popat SD; Lin CH; Davies GJ
Chembiochem; 2010 Sep; 11(14):1971-4. PubMed ID: 20665773
[No Abstract] [Full Text] [Related]
22. Rapid discovery of potent α-fucosidase inhibitors by in situ screening of a library of (pyrrolidin-2-yl)triazoles.
Elías-Rodríguez P; Moreno-Clavijo E; Carmona AT; Moreno-Vargas AJ; Robina I
Org Biomol Chem; 2014 Aug; 12(31):5898-904. PubMed ID: 24984102
[TBL] [Abstract][Full Text] [Related]
23. Design and synthesis of glycosidase inhibitor 5-amino-1,2,3,4-cyclohexanetetrol derivatives from (-)-vibo-quercitol.
Ogawa S; Asada M; Ooki Y; Mori M; Itoh M; Korenaga T
Bioorg Med Chem; 2005 Jul; 13(13):4306-14. PubMed ID: 15878669
[TBL] [Abstract][Full Text] [Related]
24. Isolation and structure assignment of an iminotetrasaccharide from a cultured filamentous cyanobacterium Anabaena sp.
Thammana S; Suzuki H; Lobkovsky E; Clardy J; Shimizu Y
J Nat Prod; 2006 Mar; 69(3):365-8. PubMed ID: 16562836
[TBL] [Abstract][Full Text] [Related]
25. Crystallographic and computational studies on 4-phenyl-N-(beta-D-glucopyranosyl)-1H-1,2,3-triazole-1-acetamide, an inhibitor of glycogen phosphorylase: comparison with alpha-D-glucose, N-acetyl-beta-D-glucopyranosylamine and N-benzoyl-N'-beta-D-glucopyranosyl urea binding.
Alexacou KM; Hayes JM; Tiraidis C; Zographos SE; Leonidas DD; Chrysina ED; Archontis G; Oikonomakos NG; Paul JV; Varghese B; Loganathan D
Proteins; 2008 May; 71(3):1307-23. PubMed ID: 18041758
[TBL] [Abstract][Full Text] [Related]
26. The 'mirror-image' postulate as a guide to the selection and evaluation of pyrrolidines as α-l-fucosidase inhibitors.
Stocker BL; Jongkees SA; Win-Mason AL; Dangerfield EM; Withers SG; Timmer MS
Carbohydr Res; 2013 Feb; 367():29-32. PubMed ID: 23295913
[TBL] [Abstract][Full Text] [Related]
27. Synthesis of branched seven-membered 1-N-iminosugars and their evaluation as glycosidase inhibitors.
Li H; Zhang Y; Favre S; Vogel P; Sollogoub M; Blériot Y
Carbohydr Res; 2012 Jul; 356():110-4. PubMed ID: 22129839
[TBL] [Abstract][Full Text] [Related]
28. Using surface plasmon resonance to directly measure slow binding of low-molecular mass inhibitors to a VanX chip.
Chang YP; Tseng MJ; Chu YH
Anal Biochem; 2006 Dec; 359(1):63-71. PubMed ID: 16965759
[TBL] [Abstract][Full Text] [Related]
29. Synthesis of 4-amino-4,5-dideoxy-L-lyxofuranose derivatives and their evaluation as fucosidase inhibitors.
Chevrier C; Le Nouën D; Defoin A; Tarnus C
Carbohydr Res; 2011 Jul; 346(10):1202-11. PubMed ID: 21550024
[TBL] [Abstract][Full Text] [Related]
30. N-Alkyl-1,5-dideoxy-1,5-imino-l-fucitols as fucosidase inhibitors: Synthesis, molecular modelling and activity against cancer cell lines.
Zhou J; Negi A; Mirallai SI; Warta R; Herold-Mende C; Carty MP; Ye XS; Murphy PV
Bioorg Chem; 2019 Mar; 84():418-433. PubMed ID: 30554081
[TBL] [Abstract][Full Text] [Related]
31. Novel alpha-L-fucosidase inhibitors from the bark of Angylocalyx pynaertii (Leguminosae).
Asano N; Yasuda K; Kizu H; Kato A; Fan JQ; Nash RJ; Fleet GW; Molyneux RJ
Eur J Biochem; 2001 Jan; 268(1):35-41. PubMed ID: 11121099
[TBL] [Abstract][Full Text] [Related]
32. Alpha-1-C-alkyl-1-deoxynojirimycin derivatives as potent and selective inhibitors of intestinal isomaltase: remarkable effect of the alkyl chain length on glycosidase inhibitory profile.
Godin G; Compain P; Martin OR; Ikeda K; Yu L; Asano N
Bioorg Med Chem Lett; 2004 Dec; 14(24):5991-5. PubMed ID: 15546715
[TBL] [Abstract][Full Text] [Related]
33. Synthesis and evaluation of alpha-fucosidase inhibitory activity of 5a-carba-alpha-L-fucopyranose and alpha-DL-fucopyranosylamine.
Ogawa S; Sekura R; Maruyama A; Odagiri T; Yuasa H; Hashimoto H
Carbohydr Lett; 2000; 4(1):13-20. PubMed ID: 11469333
[TBL] [Abstract][Full Text] [Related]
34. Inhibition of thiamin diphosphate dependent enzymes by 3-deazathiamin diphosphate.
Mann S; Perez Melero C; Hawksley D; Leeper FJ
Org Biomol Chem; 2004 Jun; 2(12):1732-41. PubMed ID: 15188040
[TBL] [Abstract][Full Text] [Related]
35. Synthesis and inhibitory activities of novel C-3 substituted azafagomines: a new type of selective inhibitors of α-L-fucosidases.
Moreno-Clavijo E; Carmona AT; Moreno-Vargas AJ; Rodríguez-Carvajal MA; Robina I
Bioorg Med Chem; 2010 Jul; 18(13):4648-60. PubMed ID: 20570156
[TBL] [Abstract][Full Text] [Related]
36. Determination of accurate KI values for tight-binding enzyme inhibitors: an in silico study of experimental error and assay design.
Murphy DJ
Anal Biochem; 2004 Apr; 327(1):61-7. PubMed ID: 15033511
[TBL] [Abstract][Full Text] [Related]
37. T-state inhibitors of E. coli aspartate transcarbamoylase that prevent the allosteric transition.
Heng S; Stieglitz KA; Eldo J; Xia J; Cardia JP; Kantrowitz ER
Biochemistry; 2006 Aug; 45(33):10062-71. PubMed ID: 16906764
[TBL] [Abstract][Full Text] [Related]
38. A second-generation ferrocene-iminosugar hybrid with improved fucosidase binding properties.
Hottin A; Scandolera A; Duca L; Wright DW; Davies GJ; Behr JB
Bioorg Med Chem Lett; 2016 Mar; 26(6):1546-1549. PubMed ID: 26897594
[TBL] [Abstract][Full Text] [Related]
39. Supramolecular azasugar clusters based on an amphiphilic fatty-acid-deoxynojirimycin derivative as multivalent glycosidase inhibitors.
Li M; Wang KR; Yang JX; Peng YT; Liu YX; Zhang HX; Li XL
J Mater Chem B; 2019 Mar; 7(9):1379-1383. PubMed ID: 32255008
[TBL] [Abstract][Full Text] [Related]
40. The spirocyclopropyl moiety as a methyl surrogate in the structure of l-fucosidase and l-rhamnosidase inhibitors.
Pearson MS; Floquet N; Bello C; Vogel P; Plantier-Royon R; Szymoniak J; Bertus P; Behr JB
Bioorg Med Chem; 2009 Dec; 17(23):8020-6. PubMed ID: 19875298
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]